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Abstract 
 
Mammographic density (MD) is a strong independent risk factor for breast cancer. Traditional 
screening for MD using X-ray mammography involves ionising radiation, which is not suitable 
for young women, those with previous radiation exposure, or those having undergone a partial 
mastectomy. Therefore, alternative approaches for MD screening that do not involve ionising 
radiation will be important as the clinical use of MD increases, and as more frequent MD testing 
becomes desirable for research purposes.  We have previously demonstrated the potential 
utility of spin relaxation-based, single-sided portable-NMR measurements for the purpose of 
MD quantification. We present here a more refined analysis by quantifying breast tissue density 
in excised samples on a continuous scale (0% to 100% fibroglandular tissue content) using 
micro-CT (CT), and comparing the results to spin-relaxation and diffusion portable-NMR 
measurements of the same samples. CT analysis of mammary tissues containing high- and 
low-MD (HMD and LMD, respectively) regions had Hounsfield Unit (HU) histograms with a 
bimodal pattern, with HMD regions exhibiting significantly higher HU values than LMD 
regions. Quantitative MD  (%HMD) values obtained using CT exhibited an excellent 
correlation with portable-NMR results, namely longitudinal spin-relaxation time constants (T1) 
and the relative tissue water content obtained from portable-NMR diffusion measurements 
(R2=0.92, p<0.0001 and R2=0.96, p<0.0001, respectively). These findings are consistent with 
our previous results demonstrating relatively high water content in HMD breast tissue, 
consistent with the high proportion of fibroglandular tissue, FGT, which in turn contains more 
abundant water-carrying HSPG proteins. We observed an excellent correlation between the T1 
values and diffusion NMR-measured relative tissue water content (R2=0.94, p<0.0001). These 
findings demonstrate, for the first time, the ability of single-sided portable NMR to accurately 
quantify MD in vitro on a continuous scale. The results also indicate that portable-NMR 
analysis can assist in the identification of features underpinning MD, namely FGT and adipose 
tissue content. Future work will involve application of portable NMR to quantifying MD in 
vivo.  
 
 
 
Keywords: Breast imaging, Mammographic Density, Single-sided portable NMR, CT, 
diffusion, spin-relaxation rate constants T1 and T2  
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1. Introduction 
 
Mammographic density (MD), also known as breast density, reflects the relative amounts of 
fibroglandular tissue (FGT) and adipose tissue (“fat”) in the breast. MD is highly clinically 
significant due to its relationship to both the risk of developing breast cancer and the reliability 
of imaging-based detection of breast cancer, which is discussed below. MD is traditionally 
quantified using X-ray mammography, the breast cancer screening method recommended by 
the World Health Organization [1] and provided to women aged 40-74 by BreastScreen in 
Australia [2]. In mammograms, high-MD regions, representing epithelial and stromal tissue, 
have a high-intensity (bright) radiographic appearance. Conversely, non-dense (fatty) breast 
tissue has a low-intensity (dark) appearance on a mammogram. The extent of density of the 
breast is commonly represented by a Breast Imaging Reporting and Data System (BI-RADS) 
score. The efficacy of mammography for cancer detection is significantly lowered when the 
breast is extremely dense mammographically (>75% dense tissue, BI-RADS category d [3]), 
62.2% in comparison to 88.2% in a fatty breast (BI-RADS category a) [4]. High MD score is 
also an independent breast cancer risk factor after adjustment for age and body mass index [5]. 
Approximately 8% of all women aged 40-74 have extremely dense breasts [6]. For these 
women the risk of developing breast cancer in their lifetime is approximately 4-5 times higher 
than for those with a low MD score, and approximately 2-fold higher than for the general 
population [7]. It may ultimately be valuable to accurately quantify the breast density of women 
and hence obtain a more accurate assessment of their breast cancer risk. Furthermore, change 
in MD on the time scale of weeks or months has potential as a predictive marker of response 
of women to antiestrogens used in both chemoprevention in the high risk setting, or as an 
adjuvant therapy for oestrogen receptor-positive breast cancers [8, 9]. Recent studies have 
indicated that the potential use of assessing change in MD as a predictive biomarker may also 
extend to other breast cancer therapies [10]. Therefore, high-frequency observation of MD may 
find utility in monitoring treatment response. However, monitoring this change through 
repeated mammography, which involves repeated exposure to X-rays, is not clinically 
justifiable due to the high added cancer risk. Mammography is also clinically unsuitable for 
young women, those with previous significant radiation exposure, or those having undergone 
a partial mastectomy.  
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Potential approaches to MD assessment that are free of ionising radiation include automated 
breast ultrasound, ultrasound elastography and transillumination breast spectroscopy, which 
display reasonable concordance with mammography, and magnetic resonance imaging (MRI). 
Fibroglandular tissue (FGT) content derived from T1-weighted clinical MRI exhibits one of the 
best observed correlations with MD [11]. However, clinical MRI is relatively costly and 
requires infrastructure typically only available in major hospitals, which limits its utility for 
women who live in rural and remote areas.  
 
Portable NMR has remarkable translational potential in that it offers much of the flexibility 
and sensitivity of clinical MRI without the high cost (both per scanning unit and per individual 
scan). It is compact and portable, which means that it can be easily deployed outside of a 
specialist facility. Crucially, like clinical MRI, portable NMR does not employ ionising 
radiation or uncomfortable breast compression inherent in mammography. Furthermore, 
portable NMR is free of claustrophobia-related patient discomfort that can be associated with 
clinical MRI.  
 
We have previously shown that a commercially available portable-NMR instrument, NMR-
Mouse, enables discrimination between regions of high and low MD (HMD and LMD, 
respectively) via longitudinal spin-relaxation rate constants, T1, [12, 13] and the relative 
amplitudes of fat and water peaks in T2 spectra  [12, 13]. However, there are notable limitations 
to those studies (summarised in Table 1), the most important of which is the binary nature of 
the HMD/LMD classification: the mammographic images used in those studies as a MD “gold 
standard” were used only to identify “HMD regions” and “LMD regions” within the samples 
and were not used to assess breast density as a continuous entity. The other significant 
limitation was that the model of the instrumentation used, NMR-Mouse PM5, enabled 
measurements only up to a 5 mm penetration depth. While this limitation was immaterial in 
the measurements of excised samples in vitro, it could potentially limit the utility of portable-
NMR measurements in vivo. 
 
 References [12, 13]  Current study 
Sample density range Binary; 5 pairs of HMD vs LMD 
samples  
Continuous; 10 samples 
representing a range of 
densities 
Maximum penetration depth 5 mm (NMR-Mouse PM5) 25 mm (NMR-Mouse PM25) 
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NMR-measured quantities T1 [12] and the relative area of 
the water T2 peak [13]. 
T1, T2 and relative water 
content from diffusion 
measurements 
Gold-standard MD 
measurements 
2D (mammography) 3D (CT) 
Statistical measure Statistically significant 
difference between HMD and 
LMD regions 
Unilateral linear regression 
MD outputs “High” versus “Low” Plot of density distribution 
throughout sample, % HMD 
Table 1: How the approaches taken in the current study differ from our previous work.  
 
We address these limitations in the present study by quantifying MD on a continuous scale, as 
opposed to the binary HMD/LMD categorisation. We used a mammogram image of the breast 
slice to guide selection of smaller breast tissue specimens across a wide range of 
mammographic densities, and then imaged these smaller excised samples using CT. This 
enabled detailed volumetric 3D reconstruction of the MD distribution within the samples. 
Volume-averaged mammographic density of each sample was quantified based on the relative 
areas of the water and fat peaks in the histograms of the Hounsfield Unit values derived from 
the 3D maps. We then subjected the same samples to a range of portable-NMR measurements 
(T1, T2 and diffusion) and examined the correlation between portable-NMR and CT results 
with a view of assessing the utility of portable NMR as a tool for continuous-scale 
quantification of MD. 
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2.  Methods 
 
2.1 Details of the two patients and breast tissue explants used in this study 
 
Two human breast tissue specimens with no evidence of malignancy were accrued each from 
high-risk prophylactic mastectomy surgeries at the Greenslopes Private Hospital, Brisbane.  
The study was approved by the Metro South Hospital and Health Services, Queensland 
(HREC/16/QPAH/107), and conducted in accordance with the Australian National Statement 
on Ethical Conduct in Human Research (2007). Women were excluded from this study if they 
had suspicious ductal carcinoma in situ or microcalcifications on radiological investigations. 
BI-RADS density scores were estimated from the pre-surgery mammogram. Post-surgery, 
mammography was performed on 1-1.5cm thick un-fixed, cranio-caudal slices of mammary 
tissue surplus to pathologists’ needs, and areas of high, medium and low MD were denoted by 
a radiologist. Ten samples of breast tissue, approximately (7 mm)3 in size, from a range of 
mammographically dense regions were then excised for analysis. Two different women were 
involved in this study; patient 1 was of BiRADs density category 3 (a) and patient 2 of BiRADs 
4 (d) and both were premenopausal. However the purpose of this study was not to compare 
%HMD or NMR T1 values to this information, but to each other.  
 
2.2 CT and MD measurements 
 
Excised pieces of breast tissue were placed inside a cylindrical 50 mL CorningTM FalconTM 
tube (Corning, Mulgrave, Victoria), with moist tissue paper placed at the end distal to the 
specimen in order to limit dehydration. The tube was then placed horizontally inside an Inveon 
CT scanner (Siemens Medical Solutions), and CT images were acquired using the Inveon 
Acquisition Workplace (IAW) software 2.0. Unless otherwise stated, the X-ray source was set 
at 30 kV and the current at 0.5 uA. Scans were done with 180 projections at full rotation using 
medium-high magnification and a binning factor of 2. The exposure time was 2350 ms per 
projection, with a total scan time of approximately 12 minutes. The CT images were 
reconstructed with the Hamming algorithm and no denoising using IAW software, resulting in 
an isotropic voxel size of 44 m. The images were calibrated in Hounsfield units (HU), where 
air and water were defined as -1000 and 0 HU, respectively.  Isotropic total variation (ITV) 
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denoising [14], modified such that all immediate surrounding voxels in 3D space were taken 
into account when determining the proximity operator, was applied to the images. The CT 
data were analysed using the Inveon Research Workplace (IRW) software. Voxel data for 
regions of interest (ROIs) were exported and assessed using Matlab.  
 
2.3 Portable-NMR measurements 
 
Immediately following CT, the breast tissue pieces were briefly blotted with lint-free tissue 
and placed in a dry 24-well plate and each examined in isolation using the NMR-Mouse PM25 
(Magritek, Wellington, New Zealand), a single-sided NMR scanner using a permanent magnet 
with a horizontal magnetic field B0 = 0.31 T and a vertical permanent magnetic field gradient 
g = 7.5 T/m [12, 13, 15, 16]. A surface coil was used to excite and detect the NMR signal. The 
thickness of the sensing slice was ~100 m. T1 measurements were made using a saturation 
recovery pulse sequence consisting of a train of 90° pulses used to saturate the longitudinal 
magnetization, followed by a variable saturation-recovery period (TSR), a CarrPurcell-
Meiboom-Gill detection block, and a fixed recovery time TR = 2000 ms. The saturation 
recovery curve was sampled at 30 TSR values exponentially spaced between 40 and 3000 ms. 
The T1 datasets were analysed using a three-parameter monoexponential least-squares fit [12]. 
A Carr-Purcell-Meiboom-Gill sequence (echo time TE = 70 s with NE = 64 echoes) was used 
for signal detection with the number of averages NS = 4.  
 
T2 measurements were made using the CPMG pulse sequence with TE = 70 s, NE = 4096, 
NS = 8 and TR = 30000 ms. The T2 datasets were analysed using a three-parameter 
monoexponential least-squares fit as well as an inverse Laplace transform (ILT) [13].  
 
Diffusion measurements were made using a stimulated-echo (STE) diffusion-encoding block 
(diffusion interval  = 10 ms, 32 equidistant values of STE echo time  ranging from 0.05 to 1 
ms) and a CPMG detection block (TE = 70 s, NE = 64, NS = 8 and TR = 2000 ms). The 
relative apparent amounts of water and fat were quantified based on a biexponential (“two-
pool”) analysis of the diffusion attenuation curves, where the rate of the initial diffusive decay 
represents the weighted average of the “fast” (water) and the “slow” (fat) diffusion coefficients; 
the terminal decay yields the weight and the diffusion coefficient of the “slow” component; 
and the weight of the fast-diffusing component can be determined by subtracting the “slow” 
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contribution from the initial weighted-average decay [17]. The weights of the fast-diffusing 
and slow-diffusing components thus determined were attributed to water and fat, respectively. 
The biexponential analysis was performed using three different numerical approaches: (1) 
Linear least-squares fitting of the initial and the terminal signal decay regions in Stejskal-
Tanner plots [17]; (2) Nonlinear biexponential least-squares fitting of the Stejskal-Tanner plots; 
and (3) Nonlinear biexponential least-squares fitting of the original non-linearised plots, Signal 
vs . The results of the three approaches were used for cross-validation and evaluation of the 
true uncertainties of the relative amounts of water and fat components in the tissue samples.   
 
The total measurement times were 5 min, 4 min and 8.5 min for each T1, T2 and diffusion 
measurement, respectively. T1 and T2 measurements were made at either 2 or 3 different depths 
in each sample, while diffusion measurements were made at either 1 or 2 depths.  
 
 
2.4 Statistics 
 
Pearson’s r coefficients and the respective p values were calculated using GraphPad Prism 7. 
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3. Results 
 
3.1. Optimisation of CT scan protocol for breast tissue density profiling 
 
We first established the CT protocol for breast tissue explants that would enable optimal 
quantification of HMD and LMD areas. A piece of non-malignant breast tissue, confirmed to 
contain both HMD and LMD regions by H&E staining (Figure 1B), was placed inside a 
cylindrical tube (Fig 1A). This type of enclosed container minimises tissue dehydration during 
image acquisition, enables the breast explant to remain sterile, and, as the Inveon CT scanner 
uses a rotating gantry, the cylindrical shape limits the generation of X-ray artefacts. Although 
CT imaging of dense objects such as bone is an established technique, this is not the case with 
soft objects like breast explants. Therefore, we optimised the X-ray voltage by scanning the 
same breast explant at 30 kV, 60 kV and 80 kV, while keeping the X-ray photon counts 
consistent. The objective was to identify the voltage that provides the greatest image contrast 
between the HMD and LMD regions and most effectively enables differentiation between 
HMD and LMD regions in the HU histograms. We also compared two reconstruction 
algorithms (Shepp-Logan and Hamming, both performed using Inveon software), and 
determined that the Hamming algorithm gave clearer images (data not shown). Images were 
denoised by applying a modification of the ITV algorithm. Based on the HU histograms, which 
depict the number of voxels within the reconstructed 3D image that exhibit a particular HU 
value, the 30 kV voltage provided the greatest spread of HU values, enabling clear separation 
of the histogram peaks corresponding to HMD from LMD regions (Figure 1C). An increase in 
the voltage led to a reduction in the HU value range as well as the degree of contrast in the 
CT images (Figure 1D). As expected, post-ITV reconstruction provided smoother images 
(Figure 1D) and more defined peaks (Figure 1C), hence all subsequent images were analysed 
with ITV applied.  
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Figure 1. Optimization of the microCT (CT) protocol for breast tissue slices. A. All tissue 
slices were scanned within a round-walled tube to minimize machine noise due to scanning 
artefacts generated from sharp-walled vessels. B. Haematoxylin and Eosin stain of formalin-
fixed, paraffin-embedded mammary tissue used in optimization, depicting a range of density 
(high dense: intense pink corresponding to stroma and glandular tissue, low dense; fat is 
washed out in processing of tissue for paraffin embedding so appears white). C. Density 
distribution plots before and after ITV de-noising, voxel number distribution is presented 
according to HU (Hounsefield Units). D. Comparable 2D view through the 3D x-ray of the 
tissue before and after the ITV de-noising protocol was applied. Exposure time for the 60kV 
protocol was 530ms, and for 80kV was 300ms. For both, projection numbers were 180, 0.5uA 
current, binning factor of 2, and medium-low magnification.  
 
3.2 Intra-sample comparison of NMR and CT measurements of mammographic density 
 
After establishing that the 30 kV protocol best differentiated HMD from LMD tissue, we 
scanned pieces of breast tissue obtained from prophylactic mastectomies from two women. 
Regions of high, medium and low MD were excised from a breast tissue slice as described in 
section 2.1. The samples were taken from various regions of the breast slices obtained from 
two different patients who had similar demographic information. The locations of the excised 
samples are shown in Figures 2A and 2B, while the corresponding post-reconstruction ITV 
CT images and HU distribution plots are shown in Figures 2C−2F (figure on next page).  
 
Consistent with Figure 1, HU histogram plots of both HMD and LMD tissue regions were 
bimodal, with two distinct and well-resolved peaks in the HU distribution plots with the 
maxima near +60 HU and −320 HU, respectively. Cross-sectional CT images of tissue that 
appeared predominantly bright (e.g. Figure 2E panel 1) had a high % HMD in the HU 
histograms. In contrast, images which appeared predominantly to have mid-range intensities 
(e.g. Figure 2E panel 6) had a low % HMD. Regions with an even mix of bright and mid-range 
intensities had approximately 50% HMD in the HU histograms (e.g. Figure 2C panel 6). 
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Figure 2. MicroCT (CT) of patient tissue of varying densities. Breast slice mammogram 
depicting where each of the breast pieces were taken for patient 1 (A) and patient 2 (B). C. 
Post-ITV de-noising was applied to images of patient 1 breast pieces (D) and patient 1 density 
distribution plots with the % HMD (CT) value were overlaid. E. Post-ITV de-noising was 
applied to images of patient 2 breast pieces with (F) and patient 2 density distribution plots 
with the % HMD (CT) value overlaid.  
 
Detailed histological examination of slice 9 and 3 from part C in figure 2 revealed key 
correlative information (figure 3, next page): Fibroglandular content (non-fat tissue) correlated 
well with 2D microCT derived from the depicted slice. In addition, and the slice with greater 
%HMD had a greater abundance HSPG proteins of all type (pan-HS), proteins which are 
known to sequester several water molecules per unit of protein.  
 
The entire sample set shown in figure 2 were then analysed using the NMR-Mouse in order to 
measure the T1 and T2 values and diffusion attenuation curves of the samples. The relative fat 
and water amounts were measured from the diffusion attenuation curves as described in 
Methods. The T1 recovery curves and the T2 decay curves exhibited monoexponential 
behaviour. Figure 4 (page 15) shows the least-squares fits of representative diffusion and T1 
datasets: Figure 4A demonstrates the suitability of the two-pool (“biexponential”) model for 
the diffusion data, while Figure 4B demonstrates the suitability of the monoexponential model 
for the T1 data. The T2 spectra obtained from ILT failed to separate fat and water peaks; the 
ILT results were therefore not used in the subsequent analysis.  
 
 
 
 
 
 
 
 
 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. High dense tissue has a increased HSPG abundance and hence greater water carrying 
capacity. Correlation between % HMD 2D optical slice, and comparable slices stained with 
haematoxylin and eosin to quantify fibroglandular tissue (stroma and glands) and Pan-HS 
antibody which detects all HSPG proteins.  
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Figure 4. Nonlinear least-squares fits of representative (A) diffusion and (B) T1 datasets (both 
datasets were acquired from the same slice within the same sample). The fit of the diffusion 
dataset was performed using the two-pool (“biexponential”) model, where the Fat component 
was assumed to exhibit a single diffusion coefficient, while the Water component was assumed 
to exhibit a different but also a single diffusion coefficient. The fit of the T1 dataset was 
performed using a monoexponential model, where the effective 1/T1 was treated as the 
weighted-average of the 1/T1 values of Fat and Water. All diffusion and T1 datasets in the 
present study were fitted using these respective models. The Figure demonstrates the absence 
of significant systematic deviations in both types of fits, and thus demonstrates the suitability 
of each fitting model for the respective type of data.   
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The results are summarised in Figure 5 (next page). Figure 5A depicts where the three NMR 
measures were taken through the tissue sample. Figure 5B shows the correlation between the 
T1 values and the relative amount of high-MD tissue (% HMD) determined from the CT HU 
distributions. Figure 5C shows the correlation between the T2 values of the same samples and 
the % HMD values measured using CT.  Figure 5D shows the correlation between the T1 
values and the relative water content obtained from NMR diffusion analysis. Figure 5E shows 
the correlation between the T2 values and the relative water content measured from diffusion 
NMR. Figure 5F shows the correlation between the relative water content obtained from NMR 
diffusion analysis and the % HMD determined from the CT HU distribution plots. All the 
correlations were statistically significant (p < 0.05). However, the three pairwise correlations 
involving T1 values, NMR diffusion-derived water content and CT-derived tissue 
composition were significantly stronger than either of the correlations involving T2. The 
correlation between NMR-diffusion water content and CT %HMD exhibited the highest 
concordance, with R2 = 0.96 (Figure 5F). T1 values exhibited a good correlation with both 
NMR-diffusion water content (R2 = 0.94, Figure 5D) and CT %HMD (R2 = 0.92, Figure 5B). 
T2 values exhibited a modest correlation with both those benchmarks (R
2 = 0.63, Figure 5E, 
and R2 = 0.61, Figure 5C, respectively).  
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Figure 5. NMR T1 vs % HMD (CT) of patient tissue slices. Location and spacing from 
which each of the NMR measures were taken, A. % HMD (mCT) correlated more strongly 
with T1, B, rather than T2 values, C. % water from NMR diffusion data also correlated with 
T1,, D, rather than T2 values, E, in the tissue samples. F. % HMD (mCT) showed the strongest 
correlation of all with % water determined from NMR diffusion data. Shown is the Pearson’s 
coefficient squared (R2) and its associated p value. All portable-NMR quantities are reported 
as the values averaged over the number of slices used.  
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4. Discussion 
 
In our previous work we demonstrated that portable NMR-measured T1 values of excised breast 
tissue samples enable reliable discrimination between HMD and LMD tissue regions [12]. 
Subsequently we have shown that the relative areas of the fat and water peaks in inverse 
Laplace transform (ILT) T2 spectra similarly enabled reliable discrimination between HMD 
and LMD regions [12, 13]. In the current study we investigated whether quantitative portable 
NMR could be used to quantify breast tissue density on a continuous scale (0% to 100%) as 
opposed to the binary HMD/LMD classifications employed in our previous studies. The 
relative areas of HMD and LMD peaks in the HU distributions derived from volumetric CT 
measurements were used as the “gold standard” in the present study. Based on this gold 
standard, we found that both T1 and diffusion portable-NMR measurements could be 
successfully used for continuous-valued quantification of MD in the excised samples. Across 
a set of excised breast tissue samples with a broad range of mammographic densities, the T1 
values correlated strongly with the % HMD measured from CT (R2=0.92, p<0.0001), while 
the relative water content measured from diffusion NMR exhibited an even stronger correlation 
with the CT data (R2=0.96, p<0.0001). The T1 and diffusion NMR results were also strongly 
correlated with each other (R2=0.94, p<0.0001).  
 
We found that the samples’ mean T2 values exhibited only a modest correlation with both the 
CT results (R2=0.61, p<0.0127) and with diffusion NMR results (R2=0.63, p<0.0109). This 
can be attributed to the fact that, unlike our previous T2 study [13], the T2 measurement 
conditions employed in the present study did not enable separation between the fat and water 
peaks in T2 relaxation spectra. This, in turn, can be attributed to a combination of the relatively 
short CPMG echo times used in the present study (60 s vs 120 s previously) and the relatively 
low magnetic field gradient of the PM25 NMR-Mouse model (7.5 T/m vs 22.5 T/m for the 
PM5 model used previously). The inverse T2 values of water measured in portable NMR are 
dominated by the diffusion contribution [18]:  
 
1
𝑇2
=  
1
𝑇2𝑇𝑟𝑢𝑒
+  
𝐷 𝛾2𝑔2
12
𝑇𝐸2          [1] 
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Therefore, the combination of lower g and shorter TE selected would have resulted in a 
lengthening of the water T2 values, resulting in an overlap of the fat and water peaks in the T2 
spectra. We emphasise that this does not disqualify T2 as a MD metric: the ability of the T2 
spectra to differentiate between HMD and LMD regions has been demonstrated in our previous 
study [13]. Rather, this negative result demonstrates the importance of careful selection of 
portable-NMR measurement parameters for MD quantification. We postulate that CPMG T2 
data acquired on a PM25 NMR-Mouse model with a longer TE (~500 s) would be suitable 
for MD quantification.  
 
We note that the correlation between portable-NMR and CT data is good despite the fact that 
the CT data were volumetric (acquired from the entire volume of the sample) but the portable-
NMR data were acquired from a small number of thin (~100 um) slices. Therefore, even in the 
presence of a perfect intrinsic agreement between the two methods, the differences in the 
volumes sampled could potentially result in differences in the apparent MD-equivalent 
quantities obtained from the two techniques. However, examination of Figure 5 suggests that 
even if such differences were present, they were very small, and there was little “sampling 
bias” in the portable-NMR results. This can be attributed to the fact that MD spatial patterns 
within breast tissue are usually irregular, and therefore portable-NMR signal can be expected 
to undergo effective averaging over HMD and LMD domains present within the tissue. This 
suggests that, under normal conditions, the apparent MD values obtained from portable NMR 
can be expected to have little sensitivity to the exact selection of the sampling slice(s).  
  
Overall, these results may indicate the potential utility of portable NMR in measuring and 
monitoring MD, however considerable further testing is needed to validate this claim. This 
includes, first and foremost, clinical in vivo testing.   
 
Further benefits of the present study include the optimisation of an approach to obtain 
equivalent 3D measures using CT instead of mammography to determine MD, which has a 
number of advantages in the research setting. In doing so, we have established a reliable 
protocol in which we now are able to (1) present X-ray images in which machine noise is 
minimized using a combination of reconstructing via the Hamming algorithm and post-
reconstruction denoising via a modified ITV algorithm, (2) present a graph of density 
distribution within the sample and (3) accurately provide volumetric % HMD values of the 
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tissue. This refined measurement and analysis methodology opens up the possibility of using 
CT on cultured breast tissue explants [19, 20] to quantify changes in either % HMD, or 
changes in the total volumetric size of the LMD and HMD regions within tissue explants over 
experimental time courses. 
 
The results of this study support our previous finding that high-MD tissue has a higher volume 
fraction of tissue water than low-MD tissue (see Figure 5). This is most likely due to water 
being the predominant chemical component (both intra- and extracellular) of FGT. Our current 
finding that % HMD is positively and apparently linearly correlated with the tissue water 
content is consistent with the ability of long proteoglycan chains to osmotically attract and 
sequester water molecules [21]. Consistent with this, we found that heparin sulphate 
proteoglycans were in greater abundance in higher %HMD than in lower %HMD samples 
(figure 3). Further to this, Stoeckelhuber and colleagues reported that breast tissue swells 
during the luteal phase of the menstrual cycle, the phase associated with a slight increase in 
breast density [22]. Proteoglycans also sequester growth factors, which can be released by 
actively growing breast tumours via their expression of heparanase. This provides a potential 
molecular mechanism for proteoglycans’ (and therefore HMD tissue’s) ability to contribute to 
the breast cancer risk [23].  
 
Our data suggest that it may be possible for this the portable-NMR approach to be used to 
investigate MD change in response to biochemical, enzymatic or hormonal treatments. Such 
work could be performed on human breast tissue cultured ex vivo, as has been done to 
investigate human breast cancer responses to hormonal stimulation [19, 20]. NMR 
measurements do not physically alter the tissue; these measurements could therefore be 
performed both at the baseline, intermediate time points and at the endpoint, allowing 
longitudinal analysis of the same tissue sample.  
 
Furthermore, the results of the current study support the use of portable NMR as a means of 
monitoring MD in human subjects, which could either complement or serve as an alternative 
to standard mammography. Studies comparing mammography, non-contrast MRI and NMR-
Mouse measurements of the upper-outer quadrant region of the breast in healthy female 
subjects are underway, in order to test the sensitivity of the NMR-Mouse in predicting MD. 
Clinical utility of this novel technology could lie in early assessment of MD status for assisting 
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in breast cancer risk prediction [24], and in monitoring MD change in women undergoing anti-
oestrogen therapies for prevention of adjuvant therapy of breast cancer [8]. In these clinical 
scenarios subtle early changes in MD may be an early indication of the efficacy of the treatment 
[8]. The use of portable NMR for MD quantification in the course of these therapies could 
enable non-responding patients to be identified early in the 5 or 10 year treatment regimen.  
 
Conclusion 
The results of the current study demonstrate the utility of portable-NMR T1 and diffusion 
measurements for quantification of MD in excised breast tissue samples. Both T1 values and 
the relative water content derived from diffusion measurements exhibited excellent quantitative 
correlation with the relative HMD tissue content derived from volumetric CT measurements 
over the full range of MD values. The results provide further support for the use of portable 
NMR for MD screening and monitoring.  
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